Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 May;21(5):547-52.
doi: 10.1007/BF02527751.

Evidence for an in Vivo and in Vitro Modulation of Endogenous Cortical GABA Release by Alpha-Glycerylphosphorylcholine

Affiliations

Evidence for an in Vivo and in Vitro Modulation of Endogenous Cortical GABA Release by Alpha-Glycerylphosphorylcholine

L Ferraro et al. Neurochem Res. .

Abstract

The effects of alpha-glycerylphosphorylcholine (alpha-GPC) on endogenous cortical GABA release were studied both in vivo and in vitro. In freely moving rats, equipped with epidural cups, alpha-GPC (30-300 mg/kg i.p.) increased GABA release. This effect was potentiated by atropine, both systematically administered (5 mg/kg i.p.) and locally applied (1.4 microM), but not by mecamylamine (4 mg/kg i.p.). The alpha-GPC-induced increase in GABA release was abolished in rats pretreated with the alpha 1 receptor antagonist prazosin (14 micrograms/kg i.p.). In cortical slices alpha-GPC (0.4 mM) increased the spontaneous GABA efflux. This effect was abolished by tetrodotoxin (0.5 microM) and prazosin (1 microM), but not by atropine (0.15 microM) or mecamylamine (2.5 microM). These results indicate that the facilitatory response by alpha-GPC on GABA release does not depend on a direct activation of either muscarinic or nicotinic receptors, but suggest the involvement of the noradrenergic system.

Similar articles

See all similar articles

References

    1. Indian J Exp Biol. 1993 Apr;31(4):348-52 - PubMed
    1. Eur J Pharmacol. 1990 Jan 10;175(2):219-23 - PubMed
    1. Br J Pharmacol. 1995 Nov;116(6):2724-8 - PubMed
    1. J Chromatogr. 1976 Apr 7;118(3):395-402 - PubMed
    1. Life Sci. 1992;50(16):PL125-8 - PubMed

Publication types

LinkOut - more resources

Feedback